Evidence map›Paper›PMID 21501160›Full record

ArticleImmunology2011

Increased sensitivity to antigen in high avidity CD8(+) T cells results from augmented membrane proximal T-cell receptor signal transduction.

Sharad K Sharma, Martha A Alexander-Miller

Open access · bronzeAbstract read
In one paragraph

Article in Immunology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Sharad K SharmaDepartment of Microbiology and Immunology, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA.
Martha A Alexander-Miller
Wake Forest University · US

Funding

Cellular Immune Response to Respiratory InfectionR01HL071985 · NHLBI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI ALEXANDER-MILLER, MARTHA ANN · 2004 to 2010
$2.4M
Control of cytotoxic T cell differentiation and activityR01AI043591 · NIAID · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI ALEXANDER-MILLER, MARTHA ANN · 1999 to 2009
$2.2M
NHLBI NIH HHS R01 HL071985NHLBI NIH HHS R01HL071985NIAID NIH HHS R01 AI043591NIAID NIH HHS R01AI043591
6 · The paper itself

Abstract

The functional avidity of a cytotoxic T lymphocyte (CTL) is known to be a critical determinant of the efficacy with which it clears pathogens. High avidity cells, which are by definition highly sensitive to peptide antigen, are superior for elimination of viruses and tumours. Our studies have established the ability of T cells to undergo avidity modulation as a result of antigen encounter. High and low avidity cells established in this manner exhibit significant differences in the amount of peptide required to elicit effector function. However, how signalling is regulated in these cells as it relates to the control of peptide sensitivity remains to be defined. To address this question, we compared T-cell receptor (TCR) signal transduction events in high and low avidity CTL generated from OT-I(rag2-) TCR transgenic mice. Our data suggest that divergent signalling is initiated at the TCR-associated CD3ζ, with low avidity CTL requiring higher amounts of pMHC to achieve threshold levels of phosphorylated CD3ζ compared with high avidity CTL. Further, this difference is transduced further downstream to mitogen-activated protein kinase and Ca(2+) signalling pathways. These results suggest that regulated control of the initiation of TCR signalling in high versus low avidity cells determines the amount of peptide required for T-cell activation.

Indexed as

Cytotoxicity, ImmunologicSignal TransductionAnimalsAntigens, BacterialAntigens, ViralDose-Response Relationship, ImmunologicFlow CytometryMiceMice, Inbred C57BLMice, TransgenicPeptidesReceptors, Antigen, T-CellT-Lymphocytes, CytotoxicAntigens, BacterialAntigens, ViralPeptidesReceptors, Antigen, T-Cell

Identifiers

PMID21501160
PMCPMC3112340
OpenAlexW1538480006

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.